Literature DB >> 33758169

The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2.

Cheng Li1, Xiaolong Tian1, Xiaodong Jia2, Jinkai Wan3, Lu Lu1, Shibo Jiang1, Fei Lan3, Yinying Lu4, Yanling Wu5, Tianlei Ying6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33758169      PMCID： PMC7985591          DOI： 10.1038/s41392-021-00536-0

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN： 2059-3635


× No keyword cloud information.
  9 in total

1.  Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.

Authors:  Jianhua Sui; Meagan Deming; Barry Rockx; Robert C Liddington; Quan Karen Zhu; Ralph S Baric; Wayne A Marasco
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

2.  Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.

Authors:  Dora Pinto; Young-Jun Park; Martina Beltramello; Alexandra C Walls; M Alejandra Tortorici; Siro Bianchi; Stefano Jaconi; Katja Culap; Fabrizia Zatta; Anna De Marco; Alessia Peter; Barbara Guarino; Roberto Spreafico; Elisabetta Cameroni; James Brett Case; Rita E Chen; Colin Havenar-Daughton; Gyorgy Snell; Amalio Telenti; Herbert W Virgin; Antonio Lanzavecchia; Michael S Diamond; Katja Fink; David Veesler; Davide Corti
Journal:  Nature       Date:  2020-05-18       Impact factor: 49.962

3.  Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.

Authors:  Jinkai Wan; Shenghui Xing; Longfei Ding; Yongheng Wang; Chenjian Gu; Yanling Wu; Bowen Rong; Cheng Li; Siqing Wang; Kun Chen; Chenxi He; Dandan Zhu; Songhua Yuan; Chengli Qiu; Chen Zhao; Lei Nie; Zhangzhao Gao; Jingyu Jiao; Xiaoyan Zhang; Xiangxi Wang; Tianlei Ying; Haibin Wang; Youhua Xie; Yanan Lu; Jianqing Xu; Fei Lan
Journal:  Cell Rep       Date:  2020-07-03       Impact factor: 9.423

4.  Sequential Emergence and Wide Spread of Neutralization Escape Middle East Respiratory Syndrome Coronavirus Mutants, South Korea, 2015.

Authors:  Yeon-Sook Kim; Abdimadiyeva Aigerim; Uni Park; Yuri Kim; Ji-Young Rhee; Jae-Phil Choi; Wan Beom Park; Sang Won Park; Yeonjae Kim; Dong-Gyun Lim; Kyung-Soo Inn; Eung-Soo Hwang; Myung-Sik Choi; Hyoung-Shik Shin; Nam-Hyuk Cho
Journal:  Emerg Infect Dis       Date:  2019-06-17       Impact factor: 6.883

5.  Identification of Human Single-Domain Antibodies against SARS-CoV-2.

Authors:  Yanling Wu; Cheng Li; Shuai Xia; Xiaolong Tian; Yu Kong; Zhi Wang; Chenjian Gu; Rong Zhang; Chao Tu; Youhua Xie; Zhenlin Yang; Lu Lu; Shibo Jiang; Tianlei Ying
Journal:  Cell Host Microbe       Date:  2020-05-14       Impact factor: 21.023

6.  Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.

Authors:  Xiaolong Tian; Cheng Li; Ailing Huang; Shuai Xia; Sicong Lu; Zhengli Shi; Lu Lu; Shibo Jiang; Zhenlin Yang; Yanling Wu; Tianlei Ying
Journal:  Emerg Microbes Infect       Date:  2020-02-17       Impact factor: 7.163

Review 7.  Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.

Authors:  Fei Yu; Rong Xiang; Xiaoqian Deng; Lili Wang; Zhengsen Yu; Shijun Tian; Ruiying Liang; Yanbai Li; Tianlei Ying; Shibo Jiang
Journal:  Signal Transduct Target Ther       Date:  2020-09-22

8.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850

9.  Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.

Authors:  Hongjing Gu; Qi Chen; Guan Yang; Lei He; Hang Fan; Yong-Qiang Deng; Shibo Jiang; Shihui Sun; Cheng-Feng Qin; Yusen Zhou; Yanxiao Wang; Yue Teng; Zhongpeng Zhao; Yujun Cui; Yuchang Li; Xiao-Feng Li; Jiangfan Li; Na-Na Zhang; Xiaolan Yang; Shaolong Chen; Yan Guo; Guangyu Zhao; Xiliang Wang; De-Yan Luo; Hui Wang; Xiao Yang; Yan Li; Gencheng Han; Yuxian He; Xiaojun Zhou; Shusheng Geng; Xiaoli Sheng
Journal:  Science       Date:  2020-07-30       Impact factor: 47.728
  9 in total
  12 in total

1.  Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.

Authors:  Sankar Prasad Chaki; Melissa M Kahl-McDonagh; Benjamin W Neuman; Kurt A Zuelke
Journal:  Microbiol Spectr       Date:  2022-05-31

Review 2.  Nanoagent-based theranostic strategies against human coronaviruses.

Authors:  Tao Feng; Chaofan Nie; Pandi Peng; Hui Lu; Tengjiao Wang; Peng Li; Wei Huang
Journal:  Nano Res       Date:  2022-01-05       Impact factor: 10.269

3.  Omicron BA.2 (B.1.1.529.2): high potential to becoming the next dominating variant.

Authors:  Jiahui Chen; Guo-Wei Wei
Journal:  Res Sq       Date:  2022-02-23

4.  Emerging vaccine-breakthrough SARS-CoV-2 variants.

Authors:  Rui Wang; Jiahui Chen; Yuta Hozumi; Changchuan Yin; Guo-Wei Wei
Journal:  ArXiv       Date:  2021-09-09

Review 5.  Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2.

Authors:  Qilong Tang; Raymond J Owens; James H Naismith
Journal:  Viruses       Date:  2021-11-03       Impact factor: 5.048

6.  Omicron BA.2 (B.1.1.529.2): high potential to becoming the next dominating variant.

Authors:  Jiahui Chen; Guo-Wei Wei
Journal:  ArXiv       Date:  2022-02-10

7.  SARS-CoV-2 Variants of Concern Increased Transmission and Decrease Vaccine Efficacy in the COVID-19 Pandemic in Palembang Indonesia.

Authors:  Ahmad Ghiffari; Chairil Anwar; Hamzah Hasyim; Iskhaq Iskandar; Muhammad Totong Kamaluddin
Journal:  Acta Biomed       Date:  2022-03-14

8.  Regional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis.

Authors:  Surendra S Negi; Catherine H Schein; Werner Braun
Journal:  Sci Rep       Date:  2022-01-21       Impact factor: 4.379

9.  Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance.

Authors:  Jiahui Chen; Rui Wang; Nancy Benovich Gilby; Guo-Wei Wei
Journal:  ArXiv       Date:  2021-12-01

Review 10.  Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19.

Authors:  Jesús Zepeda-Cervantes; Daniel Martínez-Flores; Josué Orlando Ramírez-Jarquín; Ángeles C Tecalco-Cruz; Noé Santiago Alavez-Pérez; Luis Vaca; Rosa Elena Sarmiento-Silva
Journal:  Viruses       Date:  2022-01-06       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.